Physicians' Knowledge and Application of Immunization Strategies in Patients with Inflammatory Bowel Disease: A Survey of the Italian Group for the Study of Inflammatory Bowel Disease.


Journal

Digestion
ISSN: 1421-9867
Titre abrégé: Digestion
Pays: Switzerland
ID NLM: 0150472

Informations de publication

Date de publication:
2020
Historique:
received: 16 11 2018
accepted: 04 05 2019
pubmed: 6 6 2019
medline: 17 4 2021
entrez: 6 6 2019
Statut: ppublish

Résumé

No data on European countries about knowledge and application of immunization strategies in patients with inflammatory bowel disease (IBD) are available. We designed a questionnaire aimed at exploring these issues among Italian gastroenterologists dealing with adult and paediatric IBD. An anonymous, 24-item, questionnaire was sent via e-mail to all members of the Italian Group for the study of Inflammatory Bowel Disease. Three sets of questions were formulated: (1) Characteristics of respondents; (2) General opinions on the role of vaccines in IBD patients; (3) Immunizations of IBD patients in clinical practice. Of the 455 total surveys sent, there were 198 respondents (response rate: 43.5%). The great majority of respondents (82.9%) reputed as "very important" to perform the vaccinations recommended by the guidelines in patients with IBD. The indication to immunization is given at the diagnosis of the disease by 55.6% of the respondents. The most frequently recommended vaccine in IBD patients is the annual flu vaccine, while the recommendation rate for the other vaccines is variable depending on the different pathogens. Efforts carried out by the scientific societies are required to increase the awareness of this relevant topic among physicians.

Sections du résumé

BACKGROUND BACKGROUND
No data on European countries about knowledge and application of immunization strategies in patients with inflammatory bowel disease (IBD) are available.
OBJECTIVES OBJECTIVE
We designed a questionnaire aimed at exploring these issues among Italian gastroenterologists dealing with adult and paediatric IBD.
METHODS METHODS
An anonymous, 24-item, questionnaire was sent via e-mail to all members of the Italian Group for the study of Inflammatory Bowel Disease. Three sets of questions were formulated: (1) Characteristics of respondents; (2) General opinions on the role of vaccines in IBD patients; (3) Immunizations of IBD patients in clinical practice.
RESULTS RESULTS
Of the 455 total surveys sent, there were 198 respondents (response rate: 43.5%). The great majority of respondents (82.9%) reputed as "very important" to perform the vaccinations recommended by the guidelines in patients with IBD. The indication to immunization is given at the diagnosis of the disease by 55.6% of the respondents. The most frequently recommended vaccine in IBD patients is the annual flu vaccine, while the recommendation rate for the other vaccines is variable depending on the different pathogens.
CONCLUSIONS CONCLUSIONS
Efforts carried out by the scientific societies are required to increase the awareness of this relevant topic among physicians.

Identifiants

pubmed: 31167191
pii: 000500798
doi: 10.1159/000500798
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

433-440

Informations de copyright

© 2019 S. Karger AG, Basel.

Auteurs

Fabio Salvatore Macaluso (FS)

IBD Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy, fsmacaluso@gmail.com.

Giovanni Mazzola (G)

Department of Sciences for Health Promotion " G. D'Alessandro", University of Palermo, Palermo, Italy.

Marco Ventimiglia (M)

IBD Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy.

Patrizia Alvisi (P)

Gastroenterology of Pediatric Unit, Maggiore Hospital, Bologna, Italy.

Sara Renna (S)

IBD Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy.

Lucia Adamoli (L)

Department of Sciences for Health Promotion " G. D'Alessandro", University of Palermo, Palermo, Italy.

Massimo Galli (M)

Infectious Disease Unit, Department of Biomedical and Clinical Sciences, "Luigi Sacco" University Hospital, Milan, Italy.

Alessandro Armuzzi (A)

IBD Unit, Presidio Columbus Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Sandro Ardizzone (S)

Department of Biochemical and Clinical Science "L. Sacco", University of Milan, ASST Fatebenefratelli Sacco, Milan, Italy.

Antonio Cascio (A)

Department of Sciences for Health Promotion " G. D'Alessandro", University of Palermo, Palermo, Italy.

Mario Cottone (M)

IBD Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy.

Ambrogio Orlando (A)

IBD Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH